Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors

Histone deacetylase inhibitors (HDIs) are promising anticancer therapies and have been clinically used for the treatment of hematological malignancy. However, their efficacy in solid tumors is marginal and drug resistance hampers their further clinical utility. To develop novel strategies for the HD...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene
Hauptverfasser: Lee, Su-Chan, Min, Hye-Young, Jung, Hyun Jin, Park, Kwan Hee, Hyun, Seung Yeob, Cho, Jaebeom, Woo, Jong Kyu, Kwon, So Jung, Lee, Hyo-Jong, Lee, Ho-Young
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2016
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5069101/
https://ncbi.nlm.nih.gov/pubmed/27086926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2016.92
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge